Cartilage Repair Market Analysis | Europe | 2017-2023 | MedCore

Cartilage Repair Market Analysis | Europe | 2017-2023 | MedCore

0

Articular cartilage is a connective tissue that lines the ends of bones in joints. It provides shock absorption within the joint and prevents abrasion from occurring to the articular surfaces of bone. Cartilage, in its various forms, is found in intervertebral discs, as the articular lining for joint surfaces and in the meniscal pads of the knees. All types of this tissue are poorly vascularized and, as proper healing requires adequate blood flow, cartilage is one of the slowest healing tissues of the body. Osteoarthritis is cumulative trauma that eventually wears away at cartilaginous surfaces, exposing the underlying bone to additional wear. There are few alternatives to osteobiologic cartilage repair. Damage to cartilage is difficult to treat because the tissue lacks blood supply and has limited capacity for self repair.

  • Year: 2017
  • Scope: 2013-2023
  • Region: Europe
  • Published Date: 6/1/2017
  • Pages: 474
  • Type: MedCore

Due to stringent regulation and a lack of national reimbursement in most regions, several companies which were once active in the segment, such as TiGenix and Vericel, have either completely withdrawn from the market or shifted their focus to other regions in the world. Despite the uncertainty surrounding the EMA decision, the ACI market is expected to remain the largest segment in the total cartilage repair market over the forecast period.

Articular cartilage is a connective tissue that lines the ends of bones in joints. It provides shock absorption within the joint and prevents abrasion from occurring to the articular surfaces of bone. Cartilage, in its various forms, is found in intervertebral discs, as the articular lining for joint surfaces and in the meniscal pads of the knees. All types of this tissue are poorly vascularized and, as proper healing requires adequate blood flow, cartilage is one of the slowest healing tissues of the body.

Segments Covered in This Market

  • Osteochondral Allograft Market
  • Meniscal Allograft Market
  • Autologous Chondrocyte Implantation Market
  • Osteochondral Autograft Market

Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares
  • Product Portfolios
  • Related Press Releases from Top Competitors

Companies Analyzed

TETEC is headquartered and operates in Germany, originally founded as a subsidiary of B. Braun/Aesculap in 2000. The company currently offers NOVOCART® 3D, NOVOCART® Inject and NOVOCART® Disc for cartilage repair solutions. CO.DON’s chondrosphere® remains the only ACI treatment that is feasibly approaching EMA approval. In November 2016, TiGenix completed the discontinuation of its ACI offerings by withdrawing ChondroCelect® from the market and terminating its distribution agreements with Sobi and the Finnish Red Cross Blood Service and manufacturing agreement with Pharmacell. Other companies include Arthrex, ConMed Linvatec and DePuy Mitek.

About Our In-Depth MedCore Research

Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis on a group of healthcare markets. A MedCore is one portion of that analysis that focuses on one market segment, and provides further detailed segmentation to get a much more granular set of market data.

This MedCore is also found in the full report suite titled Europe Market Report Suite for Orthopedic Biomaterials – MedSuite

Learn More about these product types



The "Europe Market Report Suite for Orthopedic Biomaterials 2017 - MedSuite" includes analysis on the following companies currently active in this market:
Fidia
Medtronic
TRB Chemedica
Meda Pharma
Sanofi Genzyme
Depuy Synthes
Bioventus
Laboratoire Genevrier
Recordati
Stryker
RTI Biologics
Croma-Pharma
Zimmer Biomet
Others include: Anika Therapeutics, Bioiberica, Documedica, Ferring, Geistlich, Integra Biologics, Kuros, LCA Pharma, Orotech, Plasmaconcept AG, Stella PharmaceuticalsAlphatec Spine, etc
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Not Exactly What You Need?
close-link
close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

Please fill out the all of the required fields and the captcha

close-link
close-link
close-link